U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06806683) titled 'Predictive Tools in Head and Neck Cancer Patients Undergoing Radiotherapy' on Oct. 21, 2024.
Brief Summary: The ITHACA study aims to improve the treatment of head and neck cancer by developing a predictive tool that helps doctors personalize care for each patient. This tool uses information such as medical history, imaging, and radiotherapy data to predict the risk of cancer recurrence, overall survival, and the likelihood of side effects.
Patients with head and neck cancer face significant challenges, including managing the side effects of treatments like radiotherapy. By tailoring treatment schedules and doses, and using advanced ...